Pascal Soriot
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2012-10-01
- Valid until
- still holds
- Published
- no source on record carries a date
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-09 · its source page states the value and the date
- Confidence
- 0.95
Sources
“Pascal Soriot will take on his new responsibilities and join the AstraZeneca PLC Board as an Executive Director on 1 October 2012. Simon Lowth will remain as AstraZeneca’s Interim Chief Executive Officer until Pascal Soriot joins.”— what the page says, read 2026-11-09
- https://www.astrazeneca.com/our-company/leadership.html
- ASTRAZENECA PLC - Form 6-K - FY2012
- https://www.wikidata.org/wiki/Q731938
Cite this claim
Plain text
AsOf. "AstraZeneca ceo: Pascal Soriot", as of 2012-10-01. Claim clm_5E921CD2E098, https://asof.is/claim/clm_5E921CD2E098, accessed 2026-11-09. Source: https://www.astrazeneca.com/our-company/leadership.html.
APA
AsOf. (2012). AstraZeneca ceo: Pascal Soriot (as of 2012-10-01) [Record clm_5E921CD2E098]. Retrieved November 9, 2026, from https://asof.is/claim/clm_5E921CD2E098 (source: https://www.astrazeneca.com/our-company/leadership.html)
BibTeX
@misc{asof_clm_5E921CD2E098,
author = {AsOf},
title = {AstraZeneca ceo: Pascal Soriot},
year = {2012},
howpublished = {\url{https://asof.is/claim/clm_5E921CD2E098}},
note = {Claim clm\_5E921CD2E098, as of 2012-10-01; source: https://www.astrazeneca.com/our-company/leadership.html},
urldate = {2026-11-09}
}On the record
/claim/clm_5E921CD2E098.md/v1/claims/clm_5E921CD2E098submit a correction